SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-078750
Filing Date
2024-06-27
Accepted
2024-06-27 21:42:15
Documents
1
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5477
  Complete submission text file 0000950170-24-078750.txt   7070
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address INCYTE CORPORATION EXPERIMENTAL STATION RTE 141 & HENRY CLAY RD. BLDG E336 WILMINGTON DE 19880
Business Address
Daly James M (Reporting) CIK: 0001560782 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 241081128